Wait a second!
More handpicked essays just for you.
More handpicked essays just for you.
Chapter 1 Developing Marketing Strategies and Plans
Chapter 1 Developing Marketing Strategies and Plans
To formulate a marketing strategy, one must
Don’t take our word for it - see why 10 million students trust us with their essay needs.
Recommended: Chapter 1 Developing Marketing Strategies and Plans
Introduction
The multinational pharmaceutical firm, Wellcome PLC, brought a product to the market to help treat the symptoms of AIDS and HIV. Wellcome PLC owns an American subsidiary known as the Burroughs Wellcome Company. In 1987, Burroughs Wellcome Company received FDA approval to sale Retrovir, which interferes with the ability of HIV infected cells to produce new virus. Burroughs Wellcome Company finds itself under siege in September 1989 by AIDS activists and various segments of the U.S. government. Despite two reductions in price in the last two years, Burroughs Wellcome Company’s executive management is under unrelenting pressure to decrease the price of Retrovir so that many more people can afford the prescription.
Definition of the problem
Burroughs Wellcome’s marketing manager or marketing executive must erect a marketing mix which pricing strategy takes into consideration the firm’s profitably, the company’s reputation, as well as government and activist pressures.
Alternatives and Uncertainties
The firm has two major alternatives that will affect the marketing manger’s pricing discretion.
1. To focus on maximizing shareholder’s wealth thus maintaining the pricing strategy
2. To focus on the needs of the general public by reducing the pricing strategy
If the firm decides to pursue alternative two, Burroughs and Wellcome must construct a new pricing strategy. Some of the firm’s uncertainties consist of the public perception of the company, the implication of the current pricing strategy to revenues, the effect to the bottom line because of the reduction in price, the impact of an introduction of a new product from other competitors in the future, and the unclear outcome on profits due to regulatory constraints.
Evaluat...
... middle of paper ...
...c Relations
The firm must initiate more public relations with the media revealing its programs and projects that bring aide to the general public. If the company had continues with the public, there would have been a less resistance toward pricing initiatives.
This plan alleviates many of the firm’s current uncertainties. With the price reduction and more public relations, there may be an improvement in the public perception of the company. The implemented plan supports continual profits and reduces the possible increase in regulatory constraints.
Conclusion
In summary, Burroughs Wellcome Company found itself under relentless pressure from government and activists to decrease the price of Retrovir. The firm had to decide whether to choose between increasing profit margin or changing the price for the ethical and social well-being of potential HIV and AIDS patients.
UST Inc. is a smokeless tobacco company with a long tradition and a recognizable brand name. A strong brand name can have lots of associations with high quality, revenues, soundness, growth, etc. But, this is one of the characteristics that can be like two edged sward. On one side, company with long tradition is expected to to operate in a stable and prosperous way as it always did, but on the other side, company itself can get too self confident and fail to see the newcomers and other threats. UST has ignored newcomers, and now they all have a growing market shares, while only UST Inc. total share, consequently, decreases. Smaller players are expanding their market share primarily by cutting prices, something that UST ignored. UST Inc. decided to fight competition not by decreasing prices, but with overstretching it product lines. However, this might not be the best solution. As the main player in the market, they had the better position to take on and win in the price war. If UST Inc. had been able to take this step, competitors probably would not be able to follow the price decrease imposed by the UST Inc and at least some of them would be shut down. So as one of the biggest drawbacks of UST's policy can be slow reaction to new market conditions and worse of all when they react the reaction is inappropriate.
A couple of Squares has a limited capacity for which to produce their products and smaller companies tend to have larger fixed costs than bigger companies. Therefore, A Couple of Squares must maximize profits in order to ensure that they will stay in business. A profit-oriented pricing objective is also useful because of A Couple of Squares’ increased sales goals. A Couple of Squares increased their sales goals due to recent financial troubles. Maximizing profits is the easiest way to meet these sales goals due to the fact that A Couple of Squares has limited production capacity. The last key consideration favors a profit-oriented pricing objective because A Couple of Squares offers a specialty product. A specialty product often has limited competition, therefore can be priced on customer value. Pricing at customer value will maximize profits as well as customer satisfaction. A Couple of Squares’ lack of production capacity, increased sales goals, and specialty product favor a profit-oriented pricing
The desired outcomes from cost reductions, such as reducing the workforce by almost half and eliminating management bonuses, are to reduce cost of goods and increase operating income. Although Harnischfeger’s cost of sales (COS) has increased from 1983 to 1984, the company appears to have reduced COS in comparison to sales from 81% to 79%. In addition, it has increased its Operating Income from $62 million in 1983 to $90 million in 1984.
As we learned from Chapter 12, price must be carefully determined and match with firm’s product, distribution, and communication strategies. (Hutt & Speh, 2012, p. 300) Therefore, there should be a strong market perspective in pricing. In order to build an effective pricing policy, marketers should focus on the value a customer places on a product or service. One of the most effective ways to do so is differentiating through value creation.
AIDS is slowly becoming the number one killer across the globe. Throughout numerous small countries, AIDS has destroyed lives, taken away mothers, and has left hopeless children as orphans. The problem remains that funding for the diseases’ medical research is limited to none. In the country Brazil, HIV/AIDS has been compared to the bubonic plague, one of the oldest yet, most deadly diseases to spread rapidly across Europe (Fiedler 524). Due to this issue, Brazil’s government has promised that everyone who has been diagnosed with either HIV or AIDS will receive free treatment; however, this treatment does not include help in purchasing HIV medications, that “carry astronomical price tags” (Fiedler 525). Generic drug companies have been able to produce effective HIV medications that are not as costly if compared to the prices given by the huge pharmaceutical companies. In contrast, the U.S. government has now intervened with these generic companies hindering them from making HIV medications, which may not be as efficient if made by the pharmaceutical companies. Not only are these drug companies losing thousands of dollars against generic drug companies, but also tremendous profit that is demanded for marketing these expensive drugs as well. “How many people must die without treatment until the companies are willing to lower their prices, or to surrender their patients so generic makers can enter market? (Fiedler 525).” With this question in mind, what ways can we eliminate the HIV/AIDS epidemic across the world? With research, education, testing, and funding we can prevent the spread of HIV to others and hopefully find a cure.
3Walker, Hugh: Market Power and Price levels in the Ethical Drug Industry; Indiana University Press, 1971, P 25.
Since the development of anti-retroviral therapy (ART) in the 1990s, HIV/AIDs has evolved from a death sentence into a treatable disease. It has presented a unique global health problem because while the treatments were very effective, they were extremely expensive, required advanced laboratory monitoring, were prescribed indefinitely, and required excellent patient compliance. In many of the developing countries devastated by AIDs/HIV, the health and societal infrastructures often had difficult supporting an effective treatment program. For that reason, it is estimated that 71% of HIV/AID cases are in sub-Saharan Africa and only 39% of of them are on ART (AVERT, 2015). Southern Africa is often considered the “epicenter” of the
Although antiretroviral treatment has reduced the toll of AIDS related deaths, access to therapy is not universal, and the prospects of curative treatments and an effective vaccine are uncertain. Thus, AIDS will continue to pose a significant public health threat for decades to come.
Due to patents, Pfizer and other companies in the pharmaceutical industry are not always competing in a monopolist’s competition. When a business has a patent they are the only manufacturer who can produce the product until the product expires, so it is clear that the firm can act as a monopoly while in control of the patent. As a monopolistic company, the company has market power, giving it the capability to adjust the market price of a good. The main goal for a monopolist and business owner is to maximize their profits, however, there are rules they have to abide by. The monopolistic companies still have to keep up with the market demand curve. The point at which they decide to produce will rest on their own acidities of revenue, risk and effort. The company also needs to know the price elasticity of the curve: the greater the price elasticity, the more a company such as Pfizer will struggle to establish high prices and a high volume.
CEO Martin Shkreli has recently come under fire after increasing the price of Daraprim, a drug that many people rely on, by 5,000%, from $13.50 per pill to $750. Despite the incredible backlash from critics around the country, Shkreli believes that he was justified in doing so, saying that it was to raise money to be able to create other pharmaceutical drugs. The question now becomes, can this 5,000% price increase be ethically justified? Through the use of Utilitarianism, I will argue that this price increase is not ethically justified. Daraprim is a drug that fights toxoplasmosis, a food-borne disease and a common complication of cancer and AIDS.
Since the early 1980’s, HIV has been an enigma in the United States and around the world. Although first a total mystery to all, it now seems to perplex scientists more than the general public. I argue that this is simply due to a lack of information. The average citizen does not realize the complexity of the virus, which can make public service announcements and campaigns difficult to create. This also makes it extremely challenging to persuade those most at risk for the disease to seek preventative measures, rather than waiting until they have contracted it. The Center for Disease Control and Prevention (CDC) estimates that, although rate of infection is declining, over 37,000 people were newly infected in 2014, with an estimated 1,122,900 people living with the infection at the end of 2015 (1). Most people are astonished that a vaccine has not been created, yet don’t bother to educate themselves on why. Even with billions of dollars poured into the creation of a vaccine, only one has made it to Phase III, where it then failed to be an effective
Overall, the product was set at this high price due to the distinctive benefits, features and values that is possessed. However this overpricing affected all aspects of the marketing mix including product, place and promotion, which in return affected the overall profit of the brand.
3. Recommendation whether the firm should or should not cut its price to increase its market share.
When a business aims to be as successful as possible in selling its products and services, it must examine in detail whether or not the products will be attractive and necessary; if the price is optimal; if the product is being distributed in the best locations; and finally, how interest and awareness can be created for the products. In order for a business to target all of these elements at the right people at the right time, it must employ the right type of marketing mix: Product, Price, Place and Promotion.